Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Asahi Kasei Corp    3407   JP3111200006

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Asahi Kasei to buy Zoll Med for up to $1.2 billion -Nikkei

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/12/2012 | 08:22am CEST

Japan's Asahi Kasei Corp will launch a tender offer bid to acquire Zoll Medical Corp, a medical equipment firm, for up to 100 billion yen ($1.2 billion), the Nikkei business daily reported on Monday.

The maker of chemicals and construction materials will be holding a press conference at 3.30 a.m. EDT, which will be attended by Taketsugu Fujiwara, the president of Asahi Kasei Corp, .

($1 = 82.3550 Japanese yen)

(Reporting by Chris Gallagher; Editing by Joseph Radford)

Stocks treated in this article : Asahi Kasei Corp., ZOLL Medical Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ASAHI KASEI CORP
08/17 ASAHI KASEI : MILITARY $48,767 Federal Contract Awarded to Zoll Medical
08/10 ASAHI KASEI : Zoll Announces Jury Verdict in Zoll/Philips Patent Dispute
08/07 ASAHI KASEI : Demonstration of validation plant for DRC process to produce DPC, ..
08/04 ASAHI KASEI : Verdict of a jury trial for damages related to a consolidated subs..
08/01 ASAHI KASEI : Homes and McDonald Jones Homes form capital alliance
07/24 ASAHI KASEI : to increase production capacity for SBR in Singapore
07/15 ASAHI KASEI : U.S. Patents Awarded to Inventors in Colorado (July 15)
07/11 ASAHI KASEI : Home Order Trends – June 2017
07/07 ASAHI KASEI : Global Hemofiltration Machines Market 2017 - Baxter Healthcare Cor..
06/29 HAEMONETICS : Global Blood Filter Market 2017 - Asahi Kasei Medical, Chengdu Shu..
More news
News from SeekingAlpha
01/19 Evotec collaborates with Japan's Asahi Kasei Pharma on drug discovery
2016 JAPANESE EQUITIES : False Dawn Or Rising Star?
2016 GMO International Active EAFE Strategy Q3 2016 Commentary
2016 A YEAR OF SCANDAL : The Beginning Of The End Of Cronyism In Japan?
2016 Array Bio licenses TrkA inhibitors to Asahi Kasei Pharma in Asia for up to $7..
Financials ( JPY)
Sales 2018 1 974 186 M
EBIT 2018 -
Net income 2018 118 541 M
Debt 2018 181 738 M
Yield 2018 1,95%
P/E ratio 2018 14,94
P/E ratio 2019 14,12
EV / Sales 2018 0,98x
EV / Sales 2019 0,92x
Capitalization 1 757 478 M
Chart ASAHI KASEI CORP
Duration : Period :
Asahi Kasei Corp Technical Analysis Chart | 3407 | JP3111200006 | 4-Traders
Technical analysis trends ASAHI KASEI CORP
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 1 199  JPY
Spread / Average Target -4,3%
EPS Revisions
Managers
NameTitle
Hideki Kobori President & Representative Director
Ichiro Itoh Chairman
Norio Ichino Independent Director
Masafumi Nakao Director
Yuji Kobayashi Representative Director
Sector and Competitors
1st jan.Capitalization (M$)
ASAHI KASEI CORP22.42%16 090
AIR LIQUIDE-2.46%47 048
SHIN-ETSU CHEMICAL CO LTD5.96%38 024
PRAXAIR, INC.12.89%37 841
LYONDELLBASELL INDUSTRIES NV1.82%34 570
AIR PRODUCTS & CHEMICALS, INC.1.20%31 769